Form 4: Humana CFO Susan M. Diamond Reports Stock Transactions
SEC Form 4 Filing
Humana's Chief Financial Officer, Susan M. Diamond, reported multiple transactions involving company stock, including the vesting of restricted stock units and the associated tax liability.
Summary
- Susan M. Diamond, Chief Financial Officer of Humana Inc., filed a Form 4 detailing changes in her beneficial ownership of company stock.
- The transactions occurred on December 15, 2024, and included the vesting of restricted stock units and the subsequent disposal of shares to cover tax liabilities.
- Diamond acquired 512 and 588 shares of Humana common stock through the vesting of restricted stock units.
- She also disposed of 393, 234, and 268 shares to cover tax obligations at a price of $271.675 per share.
- Following these transactions, Diamond directly owns 20,165 shares of Humana common stock and indirectly owns 2,213 shares through the Humana Retirement Savings Plan.
- She also holds various stock options and restricted stock units that vest over time.
Sentiment
Score: 7
Explanation: The document reflects routine transactions related to executive compensation. There are no indications of unusual activity or negative sentiment. The transactions are expected and do not suggest any significant positive or negative outlook.
Positives
- The vesting of restricted stock units indicates that performance-based incentives are being realized.
- The continued holding of a significant number of shares and options demonstrates a long-term commitment to the company by the CFO.
Negatives
- The disposal of shares to cover tax liabilities resulted in a reduction of direct share ownership, although this is a standard practice.
Risks
- Fluctuations in Humana's stock price could impact the value of Diamond's holdings and future vesting of stock options and restricted stock units.
- Changes in tax laws could affect the tax liabilities associated with stock-based compensation.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and aligns with regulatory requirements.
Comparison to Industry Standards
- Form 4 filings are standard practice for executives in publicly traded companies like Humana, similar to filings by executives at UnitedHealth Group (UNH), CVS Health (CVS), and Anthem (ANTM).
- The vesting schedules and stock option grants are typical forms of executive compensation, comparable to those offered by other large healthcare companies.
- The disposal of shares to cover tax liabilities is a common occurrence and does not indicate any unusual activity.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine and do not indicate any change in the company's fundamentals.
- The vesting of stock options and restricted stock units aligns executive interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 08/01/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 8/1/22 to 8/1/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25. Restricted stock units granted, 33% vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26. Restricted stock units granted, 33% vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 12/15/2024 | Date of stock transactions including vesting of restricted stock units and disposal of shares for tax liabilities. |
| 12/17/2024 | Date of filing of the Form 4. |
Keywords
Humana, stock transactions, Form 4, Susan M. Diamond, CFO, restricted stock units, stock options, beneficial ownership, insider trading, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.